These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18334293)

  • 1. Pyrimidine-based inhibitors of CaMKIIdelta.
    Mavunkel B; Xu YJ; Goyal B; Lim D; Lu Q; Chen Z; Wang DX; Higaki J; Chakraborty I; Liclican A; Sideris S; Laney M; Delling U; Catalano R; Higgins LS; Wang H; Wang J; Feng Y; Dugar S; Levy DE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2404-8. PubMed ID: 18334293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 1: SAR of the aryl region.
    Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Liclican A; Higaki J; Dong H; Laney M; Mavunkel B; Dugar S
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2390-4. PubMed ID: 18334294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientation.
    Lu Q; Chen Z; Perumattam J; Wang DX; Liang W; Xu YJ; Do S; Bonaga L; Higaki J; Dong H; Liclican A; Sideris S; Laney M; Dugar S; Mavunkel B; Levy DE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2399-403. PubMed ID: 18337095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 2: SAR of the amine tether.
    Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Higaki J; Dong H; Liclican A; Laney M; Mavunkel B; Dugar S
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2395-8. PubMed ID: 18334295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors.
    McInnes C; Wang S; Anderson S; O'Boyle J; Jackson W; Kontopidis G; Meades C; Mezna M; Thomas M; Wood G; Lane DP; Fischer PM
    Chem Biol; 2004 Apr; 11(4):525-34. PubMed ID: 15123247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.
    Waelchli R; Bollbuck B; Bruns C; Buhl T; Eder J; Feifel R; Hersperger R; Janser P; Revesz L; Zerwes HG; Schlapbach A
    Bioorg Med Chem Lett; 2006 Jan; 16(1):108-12. PubMed ID: 16236504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck).
    Sabat M; Vanrens JC; Brugel TA; Maier J; Laufersweiler MJ; Golebiowski A; De B; Easwaran V; Hsieh LC; Rosegen J; Berberich S; Suchanek E; Janusz MJ
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4257-61. PubMed ID: 16757169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors.
    Schirok H; Kast R; Figueroa-Pérez S; Bennabi S; Gnoth MJ; Feurer A; Heckroth H; Thutewohl M; Paulsen H; Knorr A; Hütter J; Lobell M; Münter K; Geiss V; Ehmke H; Lang D; Radtke M; Mittendorf J; Stasch JP
    ChemMedChem; 2008 Dec; 3(12):1893-904. PubMed ID: 18973168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
    Zanatta N; Amaral SS; Dos Santos JM; de Mello DL; Fernandes Lda S; Bonacorso HG; Martins MA; Andricopulo AD; Borchhardt DM
    Bioorg Med Chem; 2008 Dec; 16(24):10236-43. PubMed ID: 18996017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.
    Bogoyevitch MA; Fairlie DP
    Drug Discov Today; 2007 Aug; 12(15-16):622-33. PubMed ID: 17706543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and activity of bisubstrate, transition-state analogues and competitive inhibitors of aspartate transcarbamylase.
    Grison C; Coutrot P; Comoy C; Balas L; Joliez S; Lavecchia G; Oliger P; Penverne B; Serre V; Hervé G
    Eur J Med Chem; 2004 Apr; 39(4):333-44. PubMed ID: 15072842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A.
    Hines AC; Cole PA
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2951-4. PubMed ID: 15125966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New potential inhibitors of cyclin-dependent kinase 4: design and synthesis of pyrido[2,3-d]pyrimidine derivatives under microwave irradiation.
    Tu S; Zhang J; Zhu X; Xu J; Zhang Y; Wang Q; Jia R; Jiang B; Zhang J
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3578-81. PubMed ID: 16621547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hit to lead optimization of pyrazolo[1,5-a]pyrimidines as B-Raf kinase inhibitors.
    Gopalsamy A; Ciszewski G; Shi M; Berger D; Hu Y; Lee F; Feldberg L; Frommer E; Kim S; Collins K; Wojciechowicz D; Mallon R
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6890-2. PubMed ID: 19884006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of PI3-kinase isoforms: identification of residues enabling selective inhibition by small molecule ATP-competitive inhibitors.
    Zvelebil MJ; Waterfield MD; Shuttleworth SJ
    Arch Biochem Biophys; 2008 Sep; 477(2):404-10. PubMed ID: 18647592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors.
    Perner RJ; Lee CH; Jiang M; Gu YG; Didomenico S; Bayburt EK; Alexander KM; Kohlhaas KL; Jarvis MF; Kowaluk EL; Bhagwat SS
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2803-7. PubMed ID: 15911258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell biology. Lessons in rational drug design for protein kinases.
    Ahn NG; Resing KA
    Science; 2005 May; 308(5726):1266-7. PubMed ID: 15919981
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
    Golub AG; Yakovenko OY; Bdzhola VG; Sapelkin VM; Zien P; Yarmoluk SM
    J Med Chem; 2006 Nov; 49(22):6443-50. PubMed ID: 17064064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening.
    Park H; Bahn YJ; Jeong DG; Woo EJ; Kwon JS; Ryu SE
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5372-6. PubMed ID: 18835158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors.
    Asano S; Komiya M; Koike N; Koga E; Nakatani S; Isobe Y
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6696-8. PubMed ID: 20875738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.